Subpart C - USES AND DISCLOSURES WITH PATIENT CONSENT
- Section 2.31 - [Effective 4/16/2024] Consent requirements
- Section 2.31 - [Effective until 4/16/2024] Consent requirements
- Section 2.32 - [Effective 4/16/2024] Notice and copy of consent to accompany disclosure
- Section 2.32 - [Effective until 4/16/2024] Prohibition on re-disclosure
- Section 2.33 - [Effective 4/16/2024] Uses and disclosures permitted with written consent
- Section 2.33 - [Effective until 4/16/2024] Disclosures permitted with written consent
- Section 2.34 - [Effective 4/16/2024] Uses and Disclosures to prevent multiple enrollments
- Section 2.34 - [Effective until 4/16/2024] Disclosures to prevent multiple enrollments
- Section 2.35 - [Effective 4/16/2024] Disclosures to elements of the criminal justice system which have referred patients
- Section 2.35 - [Effective until 4/16/2024] Disclosures to elements of the criminal justice system which have referred patients
- Section 2.36 - Disclosures to prescription drug monitoring programs